Invention Application
- Patent Title: TRICYCLIC INHIBITORS OF HEPATITIS B VIRUS
-
Application No.: US17267693Application Date: 2019-08-09
-
Publication No.: US20220110943A1Publication Date: 2022-04-14
- Inventor: Raffaele DE FRANCESCO , Lorena DONNICI , Luca GUIDOTTI , Matteo IANNACONE , Romano DI FABIO , Vincenzo SUMMA , Adolfo PRANDI , Pietro RANDAZZO , Davide GORNATI , Alessandro GRILLO , Luca FERRANTE , Leda Ivanova BENCHEVA , Marilenia DE MATTEO , Marco FERRARA
- Applicant: OSPEDALE SAN RAFFAELE S.R.L. , IRBM S.P.A. , PROMIDIS S.R.L. , ISTITUTO NAZIONALE Dl GENETICA MOLECOLARE - INGM
- Applicant Address: IT Milano (MI); IT Pomezia (RM); IT Milano (MI); IT Milano (MI)
- Assignee: OSPEDALE SAN RAFFAELE S.R.L.,IRBM S.P.A.,PROMIDIS S.R.L.,ISTITUTO NAZIONALE Dl GENETICA MOLECOLARE - INGM
- Current Assignee: OSPEDALE SAN RAFFAELE S.R.L.,IRBM S.P.A.,PROMIDIS S.R.L.,ISTITUTO NAZIONALE Dl GENETICA MOLECOLARE - INGM
- Current Assignee Address: IT Milano (MI); IT Pomezia (RM); IT Milano (MI); IT Milano (MI)
- Priority: EP18188409.9 20180810
- International Application: PCT/EP2019/071408 WO 20190809
- Main IPC: A61K31/554
- IPC: A61K31/554 ; C07D515/14 ; C07D515/08 ; A61K31/407 ; C07D519/00 ; C07D513/14 ; A61P31/20
Abstract:
The present invention relates to compounds that are inhibitors of hepatitis B virus (HBV). Compounds of this invention are useful alone or in combination with other agents for treating, ameliorating, preventing or curing HBV infection and related conditions. The present invention also relates to pharmaceutical compositions containing the compounds.
Public/Granted literature
- US11504382B2 Tricyclic inhibitors of Hepatitis B virus Public/Granted day:2022-11-22
Information query
